These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36119523)

  • 1. Bioactive peptides from venoms against glioma progression.
    Majc B; Novak M; Lah TT; Križaj I
    Front Oncol; 2022; 12():965882. PubMed ID: 36119523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer potential of bioactive peptides from animal sources (Review).
    Wang L; Dong C; Li X; Han W; Su X
    Oncol Rep; 2017 Aug; 38(2):637-651. PubMed ID: 28677775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies.
    Attia N; Mashal M; Pemminati S; Omole A; Edmondson C; Jones W; Priyadarshini P; Mughal T; Aziz P; Zenick B; Perez A; Lacken M
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma.
    O'Rawe M; Kilmister EJ; Mantamadiotis T; Kaye AH; Tan ST; Wickremesekera AC
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model.
    Bonfanti AP; Barreto N; Munhoz J; Caballero M; Cordeiro G; Rocha-E-Silva T; Sutti R; Moura F; Brunetto S; Ramos CD; Thomé R; Verinaud L; Rapôso C
    Sci Rep; 2020 Apr; 10(1):5876. PubMed ID: 32246025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells.
    Momeny M; Shamsaiegahkani S; Kashani B; Hamzehlou S; Esmaeili F; Yousefi H; Irani S; Mousavi SA; Ghaffari SH
    Life Sci; 2021 Dec; 287():120100. PubMed ID: 34715143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
    Schönthal AH; Swenson SD; Chen TC; Markland FS
    Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G
    Peretti M; Raciti FM; Carlini V; Verduci I; Sertic S; Barozzi S; Garré M; Pattarozzi A; Daga A; Barbieri F; Costa A; Florio T; Mazzanti M
    Mol Cancer Ther; 2018 Nov; 17(11):2451-2461. PubMed ID: 30135216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A
    Yan A; Joachims ML; Thompson LF; Miller AD; Canoll PD; Bynoe MS
    J Neurosci; 2019 May; 39(22):4387-4402. PubMed ID: 30926752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaperone-Mediated Autophagy Ablation in Pericytes Reveals New Glioblastoma Prognostic Markers and Efficient Treatment Against Tumor Progression.
    Molina ML; García-Bernal D; Salinas MD; Rubio G; Aparicio P; Moraleda JM; Martínez S; Valdor R
    Front Cell Dev Biol; 2022; 10():797945. PubMed ID: 35419364
    [No Abstract]   [Full Text] [Related]  

  • 11. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
    Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
    Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy: Advancing glioblastoma treatment-A narrative review of scientific studies.
    Tiwari S; Han Z
    Cancer Rep (Hoboken); 2023 Dec; 7(2):e1947. PubMed ID: 38069593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases.
    Cardoso FC
    Biochem Pharmacol; 2020 Nov; 181():114107. PubMed ID: 32579958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation.
    Cobbs C; Khan S; Matlaf L; McAllister S; Zider A; Yount G; Rahlin K; Harkins L; Bezrookove V; Singer E; Soroceanu L
    Oncotarget; 2014 Feb; 5(4):1091-100. PubMed ID: 24658280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interplay of Microtubules with Mitochondria-ER Contact Sites (MERCs) in Glioblastoma.
    Grespi F; Vianello C; Cagnin S; Giacomello M; De Mario A
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Therapeutic Strategies for Glioblastoma.
    Rossignol J; Srinageshwar B; Dunbar GL
    Brain Sci; 2019 Dec; 10(1):. PubMed ID: 31888004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to pain relief using venom-derived peptides.
    Hogg RC
    Curr Med Chem; 2006; 13(26):3191-201. PubMed ID: 17168706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy.
    Cardoso AMS; Sousa M; Morais CM; Oancea-Castillo LR; Régnier-Vigouroux A; Rebelo O; Tão H; Barbosa M; Pedroso MCL; Jurado AS
    Hum Mol Genet; 2019 Aug; 28(16):2738-2751. PubMed ID: 31087038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment.
    Ceccherini E; Indovina P; Zamperini C; Dreassi E; Casini N; Cutaia O; Forte IM; Pentimalli F; Esposito L; Polito MS; Schenone S; Botta M; Giordano A
    J Cell Biochem; 2015 May; 116(5):856-63. PubMed ID: 25521525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.
    Burger MC; Zhang C; Harter PN; Romanski A; Strassheimer F; Senft C; Tonn T; Steinbach JP; Wels WS
    Front Immunol; 2019; 10():2683. PubMed ID: 31798595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.